Induced Pluripotent Stem (iPS) Cell-Derived Differentiated Cells for Bioprinting for NCATS
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- POTS_21-001318
- Agency
- National Institute on Drug Abuse National Institutes of Health, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N95021P00231 Federal contract award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Madison WI 53711, United States
Notice details come from SAM.gov. Updated .
Notice text
Pursuant to FAR Subpart 13.501, attached is the sole source justification using the format at 6.303-2, modified to reflect that the procedures in FAR subpart 13.5 were used in accordance with 41 U.S.C.1901 and made publicly available within 14 days after award of contract number 75N95021P00231.
Awarded contract 75N95021P00231 to unknown vendor for unknown amount on 2021-05-12.
Attachments
| File | Type | Posted |
|---|---|---|
| JnA_Diff_iPSCs_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Induced Pluripotent Stem (iPS) Cell-Derived Differentiated Cells for Bioprinting for NCATS | Limited / Sole Source Justification | |
| Induced Pluripotent Stem (iPS) Cell-Derived Differentiated Cells for Bioprinting for NCATS | Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity